SOPHiA GENETICS Enhances RareCyte Precision Biology Services Portfolio

Jan 18 2024
RareCyte will use the SOPHiA DDM™ Platform to support its oncology testing panel BOSTON and ROLLE, Switzerland , Jan. 18, 2024 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today announced that RareCyte Inc.

Read more

Build something bigger than your career

Enjoyed learning about life at SOPHiA from our blogs? Here are a few of our open roles

Title Country Department
Events and Marketing Communications Manager United States Marketing & Communications
Financial Systems Manager Switzerland Finance
Senior Subject Matter Expert Canada. United States Clinical Sales
Junior Data Scientist Intern - Developing Predictive Models France Data Science
Junior Data Scientist Intern France Data Science